I am extremely pleased with the results and wish I'd sought out treatment sooner"- Lorraine "All staff were lovely upon arrival, waiting area is clean, calming and quite cosy with the lighting and acoustic music
To view or add a comment, sign in Genentech Reports the US FDA's Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis #genentech #gazyva #obinutuzumab #lupusnephritis #usfda #regulatory #monoclonalantibody #nobility #regency #pii #piii #ro5072759 #rg7159 #r7159 #ga101 To view or add a comment, sign in Potential future royalty income from Metsera/Pfizer* obesity drug candidates As highlighted in our 2025 half-yearly results, IP Group has financial exposure to several of Metseras obesity drug programmes, following its acquisition of our former portfolio company Zihipp Limited in 2023
[DOI] [PubMed] [Google Scholar] 103.Zamorskii I.I., Shchudrova T.S., Linkova N.S., Nichik T.E., Khavinson V.K
NO-system organized therapy (i.e., simultaneously implied NO-system blockade (L-NAME) vs
Several drugs, including para-aminosalicylic acid, have been reported to reduce the absorption of methylcobalamin, vitamin B12
